Presently, the research & development by business enterprise, pharmaceutical industry in constant ppp $ in Estonia stands at 3.02 million, an increase of 1.95 million (182.4%) since 2019.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Estonia
No matching regions
Similar regions to Estonia
Business R&D pharmaceutical in constant PPP $
More indicators for Estonia
Government R&D in security as % of government support
2.23%
-0.15%
(2021)
Higher-education-finacing R&D financed by general university in local currency
0.00M
0.00M
(2019)
R&D financed by rest of the world in local currency
579.01M
-16.79M
(2021)
Government R&D financed by rest of the world in local currency
53.01M
-19.99M
(2021)
Business R&D financed by rest of the world in local currency
187.84M
-34.36M
(2021)
Non-profit R&D growth rate
-45.86%
-26.71%
(2022)
Estonia Business R&D pharmaceutical in constant PPP $ between 2010 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 3.02M | +1.95M |
| 2019 | 1.07M | +0.06M |
| 2018 | 1.01M | -0.30M |
| 2017 | 1.31M | +0.55M |
| 2016 | 0.76M | -0.88M |
| 2015 | 1.64M | -0.47M |
| 2014 | 2.11M | +0.20M |
| 2013 | 1.91M | +0.10M |
| 2012 | 1.82M | -4.86M |
| 2011 | 6.67M | +6.16M |
| 2010 | 0.52M |